9999999997-12-013583.txt : 20120917 9999999997-12-013583.hdr.sgml : 20120917 20120916133238 ACCESSION NUMBER: 9999999997-12-013583 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120917 DATE AS OF CHANGE: 20120916 20120917 20120916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 121093899 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(()-@_`8E/V0Q,C`P[0;(,C.C$?\99?P`"#`#75@?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``(>6P94P,@` MDN5H0!9C@6(&AAL,W`R7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I;ORH9,4*X M(3/X].N$\T!2VA1C80V^5*DN%MY]G'O7.MFK@QN)B\IH4]KR0`Q)NF3E"OMG M;`\Y_=KV:^\/.8ZHC'Q(JF\`^E-%A&#XU/#4?7-TQ,.?0-RYSN"JAA=(P2WI M(3TNX4MWP2&K)PC$($+UG10C`AY`UG,P3B>D]YG!AIL#FTK1+WU3C6N"&IAU M]B[?Z`$Z.J0QP@GB2$3`C40(20=F',CZ$1D#QB>?+[IO*J(\IKV6GA5?:D\)ZKN>)_UES% M!OD$10$?MZ.KG*BS)3?,IJOA`;.;"KYWI^)[X.\% M?$&:^[Q8<562!C%!I>U5,:AC)$#QO1+^'A_ZI3A><4_&BJMZTXL+N47`Y?R6X7A%>"6YJS]#;B(%)8.M)&`-O.Z6W2LM]O>6O]59%1S0& M;-3_?6.$FCV.Y6/[D^/UO>P=DE0`?/N/Y?88O-P>AY/;WP(,`+D'?&0-"F5N M9'-TT]F#+KF,O[;_?N8B2+/FR%0M@120/#\_E.]^AWF:= MZ_?B]>OK^_[=0&CQYLW;05]TKON/6DR?84(\3_/.=99I843VJ6.L\#5,P_]` MQR+1797&(EMUI/"ROSHW][BY4FB<0JVT#D0VA=W\]B+\0*6I\(TRD'.\P.9X8#>:)H$1&\X$#3\W3-:]G_V_%#V MAC]YQ5[1_PUG[CV_"P_+VVDG/6A($L.&,\==")P+1JLDJ``,P9^690$['PF M(9%*H[K%%*2'`07U06!\'WJ`!2V'55HH[()F.>S#6R_E)=Y8D^W]2NFAB0=8 M-)'LT0"SY(0/4V)#I=-S[B?G``:[@P-P#YTS="P!AR'S+Y''J&LCKM#RIYFJ6`&Q=P@TZ.9-_S4WG[0S/I#2Q+ MVXVZ875`R[N*/5-E:DPI_SSV=T91R6'01`PW$1]@400X.!/@DL^T.WY0=_P0 M:47@"&'!(<)B0AA`8HXX&2.\`%TP/29DA2Q3(.L$JE($%6)1\>QA=$>XP\C] M9(7YILSOR@>F?R;&\,SIN=DL2ZDIC'%N5\P8`$DN]OF,"3F0X@'=V5C'ST-R8)G:+,;PMQ6X+*SB)P]VJ7.80XS94L24R6SA- M/!7)%6U:N$/$8B=0P5>J=%2_AUEW*OX7N'M;:%B)W;Q8`QX->!O.+";XV#U[ M!MP%*W8H+?`L<>MU*X-6S8Q+HZL$'.'_P*JNJ^5?!!=W*Y`C#M:RM+EQB,]: MJMH#;*"JD7Q':=SG!`F;M.H>E,K^T8ST2I-ZK8=32^ACI#+`%P0T"Z"F\[R;:2LJ5?9%UC;%PJ7 M"X(.(H=TCMW+D5*$2#1KL<5?2$1K8J^5HQI,(4XO7+J(A,2::*FHV8!7SV/FIY' MU59#T%#!U](O4KV?%<;B+&^^D#A7"+OKBDI*3+2>;&06I M;"6UG@`ICZBD(.O0D5X0W,NEP"I:4]N:N([B^MJ2FUN+**+($6:-*(M\U%QH MI4:4T6A!KHI*6:YBX]#`T9H19NE$PJV@5Q(J"M78JH+)J%=,N^F%>W)2_S[0 MER_*W58':8FDIYK,Z0$RORD@-20<&B5V8:M))%6)/1=#J^LQ!-E&#"]Z?T)M]4V2 M7DJ+M:<;.])1"WA,8E6/J,BBSGA790N'LL?MQNW__VERZEK"%13/UJ%]/RXO M&:[*7/$;OE75FRIQ4'&]!FV4YW&=7_GJON=`K,OZVA6\"5Z^C9R%>O8$&6_KV*^SR.R?$-?2U-RC&^,"-@$NH%??$K1IQ-]3H''3??" M\\#HUMT+CR/C)NO\(\``H\/+LPT*96YDCBY,HDP,"0FU=2Y![D&!D1&:7`?IZ!C8&9`0P2DXL+'`," M?$#LO/R\5`8,\.T:`R.(OJP+,@M3'B]@32XH*@'2!X#8*"6U.!E(?P'BS/*2 M`J`X8P*0+9*4#6:#U(EDAP0Y`]D=0#9?26H%2(S!.;^@LB@S/:-$P=#2TE+! M,24_*54AN+*X)#6W6,$S+SF_J""_*+$D-06H%FH'"/"[%R56*K@GYN8F*ACI M&9'H^2'Q*93_0GE51014DHD12):A*NR!<46$2D% M1$FI0E14%P@`!%%375;$!=4UPH,'##,R)IK!1:J)`PY`#T=D],0E,C$M)^(P M3L@0B&MD%3$>1BA*$O`$IPAX4F)L\*3&X.`%-`EXH?0DX(6::1YH_AH!+\9` M`EY,D2XNW`T^O:"MVS1C[J;]F#,T_+VQSB_337XE[[;]8_[2#%`T=^Q?A^QV MTW@Z+&W;OI]6JQEY"VMHF*TM(1I!(VJ4&I5&TEC`L[4EE,)*8:6P4E@IK!16 M"BN%E2)*$:6(4D0IHA11BBA%E")*D85RYS:T5-W.[?)!/W!]>GJ^+>8G,GFG%RU^WQ-&;WL6V.8_/TMAS[X:H9?BT_=??X;W;K M^><:$G^O/G>/;9=W#PU$G[N_GJ9Y3T^!_/9'[D_3>7GZ_GP8V^%M.>3QSXT] M+O)#_^(N,=JW[CZ/;Z35ZG^ZL^59%[BY\],^4@CG.]SH"\5;MJIL5L6L!K,: MS6II5BNSFLQJ;=MX1Y9MR]NZO.W+V\*\;G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C(M8S`P,2`V,RXQ M,SDT,SDL(#(P,3`O,#DO,C&UP.DUE=&%D871A1&%T93XR M,#$R+3`Y+3$V5#$S.C(Y.C4Y+3`T.C`P/"]X;7`Z365T861A=&%$871E/@H@ M("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\+W)D9CI$97-C M&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&UP34TZ1&]C=6UE;G1)1#YU=6ED M.F9A9C$S-F8Q+3$S-3@M-#8S8RTX,F1E+68S-S5F,&$T,S@R9CPO>&UP34TZ M1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UL;G,Z9&,](FAT M='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q M+C,O(CX*("`@("`@("`@/'!D9CI02`Q,"XP/"]P9&8Z4')O9'5C97(^"B`@("`@(#PO%7N9O-H$UJJU9$ M$*N3@N#@G":W&L1>N4W`OKTIB#BX'3@_7ZY`PFJ5;H*_$2>A$^F6'D_=]LD9 M36#G'7:@6PN[UTVW5X1X/US7.6ICRJA]7)7VF%3+3*I,EFJFIEE9+,8R'TDY M^E01WQBF6GLX5?NCOB.#DA,%#3%47.C'98#!*EFH<'#BXFC7W M`R5%>J;`!J/C&H?V%YI'J!#K]5N``0`AB$?�IE;F1S=')E86T-96YD;V)J M#34@,"!O8FH-/#PO1&5C;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC=&]R M(#$R/CXO1FEL=&5R+T9L871E1&5C;V1E+TE$6SQ%,T4U14,U-S`W0C=$0S0R M0D(S0T)%-T4P.49%,#A!,#X\1D1%,C@X-3!&.#,T-D$T1CDR1CE%,T4Q0D4W M1D0U.#$^72]);F9O(#0Q(#`@4B],96YG=&@@-#DO4F]O="`T,R`P(%(O4VEZ M92`T,B]4>7!E+UA2968O5ULQ(#(@,5T^/G-T